BRUNO, Savino
 Distribuzione geografica
Continente #
NA - Nord America 594
AS - Asia 99
EU - Europa 92
AF - Africa 13
Totale 798
Nazione #
US - Stati Uniti d'America 581
SG - Singapore 44
CN - Cina 41
FI - Finlandia 22
DE - Germania 15
CA - Canada 13
IE - Irlanda 13
NG - Nigeria 13
BE - Belgio 12
IL - Israele 11
FR - Francia 8
SE - Svezia 7
IT - Italia 5
NL - Olanda 4
DK - Danimarca 2
GB - Regno Unito 2
TR - Turchia 2
IM - Isola di Man 1
IN - India 1
RO - Romania 1
Totale 798
Città #
Chandler 148
Wilmington 91
Boardman 40
Shanghai 34
Ann Arbor 31
Singapore 31
San Mateo 29
Ashburn 22
Helsinki 22
Leawood 22
New York 20
Lawrence 14
Princeton 14
Benin City 13
Brussels 12
Dublin 12
Toronto 12
Paris 8
Seattle 6
Woodbridge 6
Fairfield 5
Amsterdam 4
Falls Church 3
San Diego 3
Falkenstein 2
Frankfurt am Main 2
Kocaeli 2
London 2
Milan 2
Norwalk 2
Santa Clara 2
Torino 2
Apo 1
Clearwater 1
Des Moines 1
Douglas 1
Gorey 1
Gunzenhausen 1
Hangzhou 1
Houston 1
Iasi 1
Media 1
Monmouth Junction 1
Ningbo 1
Pune 1
Redmond 1
San Francisco 1
Shijiazhuang 1
Winnipeg 1
Totale 635
Nome #
Lack of Correlation Between Serum Anti-HBcore Detectability and Hepatocellular Carcinoma in Patients With HCV-Related Cirrhosis 78
Real life experiences in HCV management in 2018 68
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 66
Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response 63
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 63
Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population 61
Colifagina, a novel preparation of 8 lysed bacteria ameliorates experimental colitis 61
From current status to optimization of HCV treatment: Recommendations from an expert panel 60
Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class A liver cirrhosis 59
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65years with HCV genotype 1 cirrhosis 57
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 56
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 46
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel 36
Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease After Haploidentical Stem Cell Transplantation and Post-Transplant Cyclophosphamide 24
Toward precision medicine in primary biliary cholangitis 6
Totale 804
Categoria #
all - tutte 5.139
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.139


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 0 0 2
2020/2021166 1 2 0 1 0 48 41 11 24 22 3 13
2021/2022113 1 3 1 17 6 3 11 12 6 10 30 13
2022/2023303 30 30 18 50 18 34 0 31 60 21 8 3
2023/2024175 12 12 24 17 8 28 25 16 3 2 5 23
2024/202545 16 13 5 6 5 0 0 0 0 0 0 0
Totale 804